112 related articles for article (PubMed ID: 15252833)
21. Effects of tumor necrosis factor alpha in renal cell carcinoma.
Ikemoto S; Narita K; Yoshida N; Wada S; Kishimoto T; Sugimura K; Nakatani T
Oncol Rep; 2003; 10(6):1947-55. PubMed ID: 14534724
[TBL] [Abstract][Full Text] [Related]
22. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
[TBL] [Abstract][Full Text] [Related]
23. A spliced isoform of interleukin 6 mRNA produced by renal cell carcinoma encodes for an interleukin 6 inhibitor.
Alberti L; Bachelot T; Duc A; Biota C; Blay JY
Cancer Res; 2005 Jan; 65(1):2-5. PubMed ID: 15665272
[TBL] [Abstract][Full Text] [Related]
24. Effect of interleukin-6 on the growth of human lung cancer cell line.
Fu J; Zheng J; Fang W; Wu B
Chin Med J (Engl); 1998 Mar; 111(3):265-8. PubMed ID: 10374431
[TBL] [Abstract][Full Text] [Related]
25. Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53.
Angelo LS; Talpaz M; Kurzrock R
Cancer Res; 2002 Feb; 62(3):932-40. PubMed ID: 11830554
[TBL] [Abstract][Full Text] [Related]
26. [Interleukin-6 behaves as an autocrine growth stimulator for a human lung giant cell carcinoma cell line].
Fu J; Zheng J; Fang W
Zhonghua Bing Li Xue Za Zhi; 1997 Feb; 26(1):5-7. PubMed ID: 10072840
[TBL] [Abstract][Full Text] [Related]
27. A novel and rapid prediction assay for the effectiveness of IL-6 receptor specific antisense oligonucleotides by proliferation inhibition of an interleukin-6 dependent cell line.
Lia Varga V; Falus A; Pallinger E; Novák I; Fülöp KA; Toth S; Rose-John S
Cell Biol Int; 2001; 25(3):253-6. PubMed ID: 11352498
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
Kausch I; Jiang H; Thode B; Doehn C; Krüger S; Jocham D
Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
[TBL] [Abstract][Full Text] [Related]
29. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides.
Gnarra JR; Dressler GR
Cancer Res; 1995 Sep; 55(18):4092-8. PubMed ID: 7664285
[TBL] [Abstract][Full Text] [Related]
30. Disialosyl galactosylgloboside as an adhesion molecule expressed on renal cell carcinoma and its relationship to metastatic potential.
Satoh M; Handa K; Saito S; Tokuyama S; Ito A; Miyao N; Orikasa S; Hakomori S
Cancer Res; 1996 Apr; 56(8):1932-8. PubMed ID: 8620516
[TBL] [Abstract][Full Text] [Related]
31. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
Prewett M; Rothman M; Waksal H; Feldman M; Bander NH; Hicklin DJ
Clin Cancer Res; 1998 Dec; 4(12):2957-66. PubMed ID: 9865906
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas.
Adachi Y; Aoki C; Yoshio-Hoshino N; Takayama K; Curiel DT; Nishimoto N
Int J Cancer; 2006 Sep; 119(6):1303-11. PubMed ID: 16642474
[TBL] [Abstract][Full Text] [Related]
33. [Studies on the interaction between interleukin-6 and human renal cell carcinoma cell line GRC-1].
Xi Z; Yu L; Guo Y
Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):308-11. PubMed ID: 11798778
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro.
Okamoto M; Hattori K; Oyasu R
Int J Cancer; 1997 Jul; 72(1):149-54. PubMed ID: 9212236
[TBL] [Abstract][Full Text] [Related]
35. [Interleukin-6 functions as an autocrine growth stimulator for a human lung adenocarcinoma cell line PAa].
Fu J; Fang W; Zheng J
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):45-8. PubMed ID: 10743055
[TBL] [Abstract][Full Text] [Related]
36. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.
Kuznetsov VA; Puri RK
Biophys J; 1999 Jul; 77(1):154-72. PubMed ID: 10388747
[TBL] [Abstract][Full Text] [Related]
37. Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains.
Schwabe M; Brini AT; Bosco MC; Rubboli F; Egawa M; Zhao J; Princler GL; Kung HF
J Clin Invest; 1994 Dec; 94(6):2317-25. PubMed ID: 7989587
[TBL] [Abstract][Full Text] [Related]
38. Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs.
Frankenberger B; Pohla H; Noessner E; Willimsky G; Papier B; Pezzutto A; Kopp J; Oberneder R; Blankenstein T; Schendel DJ
Clin Cancer Res; 2005 Mar; 11(5):1733-42. PubMed ID: 15755994
[TBL] [Abstract][Full Text] [Related]
39. The effects of five hematopoietic growth factors on human small cell lung carcinoma cell lines: interleukin 3 enhances the proliferation in one of the eleven cell lines.
Vellenga E; Biesma B; Meyer C; Wagteveld L; Esselink M; de Vries EG
Cancer Res; 1991 Jan; 51(1):73-6. PubMed ID: 1703041
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized, and carcinoma-derived cervical cells in vitro.
Iglesias M; Plowman GD; Woodworth CD
Am J Pathol; 1995 Apr; 146(4):944-52. PubMed ID: 7717461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
